Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHY606 as Adjunct Therapy for Anemia
NCT04974073Phase 3Completed
- Start
- Aug 2017
- Primary completion
- Aug 2017
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Danggui Buxue Tang in anemia (3 arms). Primary endpoints: Constitution in Chinese Medicine Questionnaire at Day 180 and Serum Cytokines at Day 93. Started Aug 2017; status: completed.
02
Drugs
Danggui Buxue Tang
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04974073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04974073.